Detalhe da pesquisa
1.
AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication.
Br J Cancer
; 130(8): 1249-1260, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38361045
2.
Prognostic value of regulatory T cells and T helper 17 cells in high grade serous ovarian carcinoma.
J Cancer Res Clin Oncol
; 149(6): 2523-2536, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35763108
3.
LRP1B-a prognostic marker in tubo-ovarian high-grade serous carcinoma.
Hum Pathol
; 141: 158-168, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37742945
4.
Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer.
Neoplasia
; 44: 100934, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37703626
5.
Low Expression of RGS2 Promotes Poor Prognosis in High-Grade Serous Ovarian Cancer.
Cancers (Basel)
; 14(19)2022 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36230542
6.
DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumors.
Genome Med
; 14(1): 24, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35227293